N

NeGIO Therapeutics (Public limited company)

BE 0799.822.012 Active ●Rue Clément Ader 10, 6041 Charleroi

NeGIO Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0799.822.012. It was founded on 22-03-2023. Its registered office is in Charleroi. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 4 751 137 and a loss of € 607 875. These accounts report 1.5 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0799.822.012
VAT registered
Yes
Founded
22-03-2023
Latest accounts
2025
Employees
1.5 FTE
Region
Wallonia
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Rue Clément Ader 10, 6041 Charleroi
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base

Key figures of NeGIO Therapeutics

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -607 875+77 %€ -2 663 400-29 %€ -2 062 572
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 4 751 137-11 %€ 5 359 012-33 %€ 8 022 412
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 4 763 493-16 %€ 5 699 030-32 %€ 8 398 442
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -196 240+90 %€ -2 056 776-19 %€ -1 726 793
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
1.5-77 %6.5+150 %2.6

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
7 mandates on record in the annual accounts. 2 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Charleroi.

CompanyTown
Catalent Gosselies 6041 Charleroi
3D Fibroscreen 6041 Charleroi
EPICS THERAPEUTICS 6041 Charleroi
Minoryx Therapeutics BE 6041 Charleroi
KOKUMA 6041 Charleroi
INCHINN THERAPEUTICS 6041 Charleroi
OncoRNA 6041 Charleroi
AdipoPharma Belgique 6041 Charleroi
Looking for more information about NeGIO Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is NeGIO Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists NeGIO Therapeutics as active.

What is the VAT number of NeGIO Therapeutics? The VAT number of NeGIO Therapeutics is BE 0799.822.012.

When was NeGIO Therapeutics founded? NeGIO Therapeutics was founded on 22-03-2023.

What is the address of NeGIO Therapeutics? The current registered office of NeGIO Therapeutics is Rue Clément Ader 10, 6041 Charleroi.

When did NeGIO Therapeutics last file annual accounts? The latest annual accounts of NeGIO Therapeutics were filed on 26-05-2026.

Does NeGIO Therapeutics file its annual accounts on time? Yes. NeGIO Therapeutics filed its annual accounts within the legal deadline for each of its last 3 financial years.

How many employees does NeGIO Therapeutics have? NeGIO Therapeutics employs 1.5 full-time equivalents according to its most recent annual accounts.

Is NeGIO Therapeutics financially healthy? Addrly gives NeGIO Therapeutics a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is NeGIO Therapeutics profitable? The annual accounts of NeGIO Therapeutics for 2025 show a loss of € 607 875.

What is the equity of NeGIO Therapeutics? The equity of NeGIO Therapeutics was € 4 751 137 at the close of the 2025 financial year.

Who are the directors of NeGIO Therapeutics? The annual accounts of NeGIO Therapeutics record 7 mandates. The names, roles and dates are visible with a free account.

Can NeGIO Therapeutics receive Peppol e-invoices? Yes. NeGIO Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does NeGIO Therapeutics do? The main activity of NeGIO Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data